Alteraciones retinianas detectadas por screening con cámara retinal no midriática y derivación a oftalmología en una población de alto riesgo cardiovascular / Retinal alterations detected by non-mydriatic retinal camera screening and referral to ophthalmology in a population with high cardiovascular risk

Objetivo Describir las principales alteraciones retinianas detectadas por screening con cámara retinal no midriática y evaluar los factores relacionados con la derivación a oftalmología en una población de alto riesgo cardiovascular en Palmira, Colombia. Materiales y métodos Estudio observacional de tipo transversal, con 11.983 registros fotográficos de pacientes con hipertensión y diabetes mellitus del programa de enfermedades crónicas de Gesencro S.A.S. entre 2018 y 2020. Se evaluaron con regresión logística los factores de riesgo relacionados con la derivación a oftalmología y se obtuvieron los odds ratios (OR) crudos y ajustados. Resultados Se analizaron 11.880 registros; la edad media fue de 67,7±12años, y el 69,5% fueron mujeres. Entre las alteraciones retinianas se encontraron pacientes con retinopatía diabética clasificada como más que leve (10%) y gradoI de retinopatía hipertensiva (54,9% ojo derecho, 51,9% ojo izquierdo). También se identificó edema macular (15%). Solo 2.069 (17,4%) pacientes requirieron derivación a oftalmología; el 81,3% requirieron control a 1año y el 1,3% a los 6meses. En el análisis multivariado los factores de riesgo que se relacionaron con la probabilidad para ser derivados fueron: el género masculino, la edad mayor o igual a 60años, la hemoglobina glucosilada (HbA1c) fuera de metas, la enfermedad renal crónica avanzada y la razón microalbúmina-creatinina moderada a severamente elevada. Conclusión Este estudio permitió determinar la importancia que tiene el screening con cámara retinal no midriática en pacientes de alto riesgo cardiovascular para detectar alteraciones retinianas y evaluar factores de riesgo asociados con derivación a oftalmología. El documentar tempranamente el compromiso ocular en estos pacientes podría prevenir y evitar la discapacidad visual y la ceguera (AU)

Objective To describe the main retinal alterations detected by non-mydriatic retinal camera screening and to evaluate factors related to referral to ophthalmology in a population at high cardiovascular risk in Palmira, Colombia. Materials and methods Cross-sectional observational study, which included 11,983 photographic imaging records of patients with hypertension and diabetes mellitus from Gesencro's S.A.S. comprehensive chronic disease care program between 2018 and 2020. Risk factors associated to referral to ophthalmology were evaluated with logistic regression, and crude and adjusted ORs (odds ratios) were obtained. Results A total of 11,880 records were analyzed; 67.7±12years old, and 69.5% were women. Among the retinal alterations were patients with diabetic retinopathy classified as more than mild in 10% and gradeI hypertensive retinopathy in 54.9% right eye, 51.9% left eye. Macular edema was also identified. Only 2069 patients (17.4%) required referral to ophthalmology, and for imaging control 82.6%. In the multivariate analysis, the risk factors associated with the probability of being referred were male gender, age 60years and older, glycosylated hemoglobin out-of-target, advanced chronic kidney disease and the microalbumin-to-creatinine ratio moderate to severely elevated. Conclusion This study makes it possible to determine the importance of screening with a non-mydriatic retinal camera in patients at high cardiovascular risk to detect retinal abnormalities and assess risk factors associated with referral to ophthalmology. Early documentation of ocular compromise in these patients could prevent and avoid visual impairment and blindness (AU)

[Retinal alterations detected by non-mydriatic retinal camera screening and referral to ophthalmology in a population with high cardiovascular risk]. / Alteraciones retinianas detectadas por screening con cámara retinal no midriática y derivación a oftalmología en una población de alto riesgo cardiovascular.

OBJECTIVE: To describe the main retinal alterations detected by non-mydriatic retinal camera screening and to evaluate factors related to referral to ophthalmology in a population at high cardiovascular risk in Palmira, Colombia. MATERIALS AND METHODS: Cross-sectional observational study, which included 11,983 photographic imaging records of patients with hypertension and diabetes mellitus from Gesencro's S.A.S. comprehensive chronic disease care program between 2018 and 2020. Risk factors associated to referral to ophthalmology were evaluated with logistic regression, and crude and adjusted ORs (odds ratios) were obtained. RESULTS: A total of 11,880 records were analyzed; 67.7±12years old, and 69.5% were women. Among the retinal alterations were patients with diabetic retinopathy classified as more than mild in 10% and gradeI hypertensive retinopathy in 54.9% right eye, 51.9% left eye. Macular edema was also identified. Only 2069 patients (17.4%) required referral to ophthalmology, and for imaging control 82.6%. In the multivariate analysis, the risk factors associated with the probability of being referred were male gender, age 60years and older, glycosylated hemoglobin out-of-target, advanced chronic kidney disease and the microalbumin-to-creatinine ratio moderate to severely elevated. CONCLUSION: This study makes it possible to determine the importance of screening with a non-mydriatic retinal camera in patients at high cardiovascular risk to detect retinal abnormalities and assess risk factors associated with referral to ophthalmology. Early documentation of ocular compromise in these patients could prevent and avoid visual impairment and blindness.

Nutritional Assessment in Patients with Early-Onset Autosomal Dominant Alzheimer's Disease Due to PSEN1- E280A Genetic Variant: A Cross-Sectional Study.

Background: Weight loss and malnutrition are frequent findings in late-onset and sporadic presentations of Alzheimer's Disease (AD). However, less is known about nutritional status in Early-Onset Autosomal Dominant AD (EO-ADAD). Objective: To analyze the association between nutritional status and other clinical and sociodemographic characteristics in individuals with a genetic form of EO-ADAD. Design settings and participants: Cross-sectional study with 75 non-institutionalized participants from a cohort of Autosomal Dominant AD (13 with mild cognitive impairment and 61 with dementia, ages from 38 to 67 years) underwent a structured clinical assessment with emphasis on nutritional status. Measurements: Primary outcome was nutritional status and it was measured using the Mini Nutritional Assessment (MNA). Patients were categorized according to MNA total score, as undernourished (MNA ≤23.5) and well-nourished (MNA ≥ 24). Sociodemographic and clinical variables identified as potential predictors or confounders of nutritional status were also collected. Results: Undernourishment by MNA was present in 57.3% of the sample. Forty-two percent of participants had abnormal BMI values considered lower than 18.5 or higher than 24.9 kg/m2. Total BMI values were similar in well and undernourished patients (median 24.2 IQR 3.59 and median 23.9 IQR 4.42, respectively, p=0.476). When comparing well and undernourished groups, we found statistically significant differences for variables: severity of dementia (p=0.034), frailty (p=0.001), multimorbidity (p=0.035) and, polymedication (p=0.045). Neither adjusted logistic regression nor the Poisson regression showed that any clinical or sociodemographic variables explained undernourishment. Conclusions: Undernourishment was a frequent finding in our sample of EO-ADAD, especially in later stages of the disease. Patients with polymedication, multimorbidity, frailty and severe dementia show differences in their nutritional status with a tendency to be more frequently undernourished. Further studies with larger sample sizes are needed to establish this association.

Intoxicaciones en pediatría con fines suicidas: reporte de dos casos / Poisoning in pediatrics for suicidal purposes: report of two cases / Intoxicações em pediatria com fins suicidas: relato de dois casos

El suicidio es una importante causa de mortalidad en adolescentes, y en Colombia los pesticidas constituyen, para el 2014, la segunda causa más frecuente de intoxicaciones por sustancias químicas. Esto evidencia la necesidad de abordar esta temática, aún más en el contexto pediátrico. Los casos que se presentan hacen referencia a intentos suicidas mediante uso de organofosforados y monofluoroacetato de sodio (un rodenticida). El vacío en la literatura en cuanto al manejo de las intoxicaciones por pesticidas en el paciente pediátrico y, especialmente, por monofluoroacetato de sodio, constituye una oportunidad de mejora el abordaje con el fin de reducir la morbimortalidad de estos pacientes.

Suicide is one of the most important causes of mortality in teenagers. In 2014, pesticides were the second most frequent source for chemical poisoning in Colombia. This shows the need of addressing the topic, all the more important in the pediatric scenario. The cases presented below refer to suicide attempts related to the use of Organophosphates and Sodium Fluoroacetate (a rodenticide). The gap in the literature regarding the management of pediatric poisoning pesticides, more particularly related to Sodium Fluoroacetate, presents an opportunity for improvement in the approach and the impact on morbidity and mortality of these patients.

O suicídio é uma importante causa de mortalidade em adolescentes, e na Colômbia os pesticidas constituem, para 2014, a segunda causa mais frequente de intoxicações por sustâncias químicas. Isto evidência a necessidade de abordar esta temática, ainda mais no contexto pediátrico. Os casos que se apresentam fazem referência a tentativas suicidas mediante uso de organofosforados e monofluoroacetato de sódio (um raticida). O vazio na literatura em quanto ao manejo das intoxicações por pesticidas no paciente pediátrico e, especialmente, por monofluoroacetato de sódio, constitui uma oportunidade de melhora a abordagem com o fim de reduzir a morbimortalidade destes pacientes.

Ablación cardiaca auricular: estrategias guiadas por el mapeo de electrogramas / Catheter Ablation for Atrial Fibrillation: Electrogram-Guided Methods

Resumen La ablación por radiofrecuencia se ha constituido como la técnica más utilizada para el tratamiento intervencionista de la fibrilación auricular. El aislamiento eléctrico de venas pulmonares se ha convertido en el procedimiento convencional, principalmente en pacientes con fibrilación auricular paroxística. Sin embargo, la tasa de éxito mediante esta técnica en pacientes con fibrilación auricular persistente es alrededor del 50%. Aunque se han propuesto diversas estrategias para guiar al electrofisiólogo en los procedimientos de ablación, estudios recientes muestran que la generación de líneas de ablación adicionales guiadas anatómicamente o mediante mapeo de electrogramas complejos fragmentados, no mejora la tasa de éxito del procedimiento convencional de aislamiento de venas pulmonares. En esta revisión, se consideran las limitaciones que representan los métodos de mapeo electrofisiológicos actuales, las nuevas estrategias de evaluación de los electrogramas y los métodos de procesamiento de señales que se ven propuestos en el futuro más inmediato, para guiar los procedimientos de ablación particularmente en pacientes con fibrilación auricular persistente.

Abstract Radiofrequency catheter ablation has evolved into an effective treatment option for drug-resistant patients with atrial fibrillation. Electrical isolation of the pulmonary veins has become the standard ablation strategy mainly in patients with paroxysmal atrial fibrillation. However, the success rate of pulmonary veins isolation is about 50% in patients with persistent atrial fibrillation. Although different strategies to guide the electrophysiologist in ablation procedures have been proposed. Recent studies show that the generation of additional ablation lines guided anatomically or by fragmented complex electrograms mapping does not improve the success rate of the conventional pulmonary veins isolation procedure. In this review, we describe the limitations of current electrophysiological mapping methods, the new electrogram evaluation strategies and the signal processing methods that are proposed in the immediate future, to guide ablation procedures, particularly in patients with atrial fibrillation persistent.

The Value of Pre-Screening in the Alzheimer's Prevention Initiative (API) Autosomal Dominant Alzheimer's Disease Trial.

The Alzheimer's Prevention Initiative (API) Autosomal Dominant Alzheimer's Disease (ADAD) trial evaluates the anti-amyloid-ß antibody crenezumab in cognitively unimpaired persons who, based on genetic background and age, are at high imminent risk of clinical progression, and provides a powerful test of the amyloid hypothesis. The Neurosciences Group of Antioquia implemented a pre-screening process with the goals of decreasing screen failures and identifying participants most likely to adhere to trial requirements of the API ADAD trial in cognitively unimpaired members of Presenilin1 E280A mutation kindreds. The pre-screening failure rate was 48.2%: the primary reason was expected inability to comply with the protocol, chiefly due to work requirements. More carriers compared to non-carriers, and more males compared to females, failed pre-screening. Carriers with illiteracy or learning/comprehension difficulties failed pre-screening more than non-carriers. With the Colombian API Registry and our prescreening efforts, we randomized 169 30-60 year-old cognitively unimpaired carriers and 83 non-carriers who agreed to participate in the trial for at least 60 months. Our findings suggest multiple benefits of implementing a pre-screening process for enrolling prevention trials in ADAD.

APOE*E2 allele delays age of onset in PSEN1 E280A Alzheimer's disease.

Alzheimer's disease (AD) age of onset (ADAOO) varies greatly between individuals, with unique causal mutations suggesting the role of modifying genetic and environmental interactions. We analyzed ~50 000 common and rare functional genomic variants from 71 individuals of the 'Paisa' pedigree, the world's largest pedigree segregating a severe form of early-onset AD, who were affected carriers of the fully penetrant E280A mutation in the presenilin-1 (PSEN1) gene. Affected carriers with ages at the extremes of the ADAOO distribution (30s-70s age range), and linear mixed-effects models were used to build single-locus regression models outlining the ADAOO. We identified the rs7412 (APOE*E2 allele) as a whole exome-wide ADAOO modifier that delays ADAOO by ~12 years (ß=11.74, 95% confidence interval (CI): 8.07-15.41, P=6.31 × 10(-8), PFDR=2.48 × 10(-3)). Subsequently, to evaluate comprehensively the APOE (apolipoprotein E) haplotype variants (E1/E2/E3/E4), the markers rs7412 and rs429358 were genotyped in 93 AD affected carriers of the E280A mutation. We found that the APOE*E2 allele, and not APOE*E4, modifies ADAOO in carriers of the E280A mutation (ß=8.24, 95% CI: 4.45-12.01, P=3.84 × 10(-5)). Exploratory linear mixed-effects multilocus analysis suggested that other functional variants harbored in genes involved in cell proliferation, protein degradation, apoptotic and immune dysregulation processes (i.e., GPR20, TRIM22, FCRL5, AOAH, PINLYP, IFI16, RC3H1 and DFNA5) might interact with the APOE*E2 allele. Interestingly, suggestive evidence as an ADAOO modifier was found for one of these variants (GPR20) in a set of patients with sporadic AD from the Paisa genetic isolate. This is the first study demonstrating that the APOE*E2 allele modifies the natural history of AD typified by the age of onset in E280A mutation carriers. To the best of our knowledge, this is the largest analyzed sample of patients with a unique mutation sharing uniform environment. Formal replication of our results in other populations and in other forms of AD will be crucial for prediction, follow-up and presumably developing new therapeutic strategies for patients either at risk or affected by AD.

Deciphering interference control in adults with ADHD by using distribution analyses and electromyographic activity.

A deficit in "interference control" is commonly found in adults with Attention Deficit Hyperactivity Disorder (ADHD). This has mainly been interpreted as difficulties in inhibiting inappropriate responses. However, interference control involves processes other than simply the ability to inhibit. Consequently, we used sophisticated analysis to decipher the additional processes of interference control in these patients. We compared interference control between 16 adults with ADHD and 15 control adults performing a Simon task. In most studies, performance is generally reported in terms of mean error rates and reaction times (RTs). However, here we used distribution analyses of behavioral data, complemented by analyses of electromyographic (EMG) activity. This allowed us to better quantify the control of interference, specifically the part that remains hidden when pure correct trials are not distinguished from partial errors. Partial errors correspond to sub-threshold EMG bursts induced by incorrect responses that immediately precede a correct response. Moreover, besides "online" control, we also investigated cognitive control effects manifesting across consecutive trials. The main findings were that adults with ADHD were slower and showed a larger interference effect in comparison to controls. However, the data revealed that the larger interference effect was due neither to higher impulse expression, nor to a deficit in inhibition but that these patients presented a larger interference effect than the controls after congruent trials. We propose and discuss the hypothesis that the interference control deficit found in adults with ADHD is secondary to impairments in sustained attention.

Fractionated electrograms and rotors detection in chronic atrial fibrillation using model-based clustering.

The identification of atrial fibrillation (AF) substrates is needed to improve ablation therapy guided by electrograms, although mechanisms that sustain AF are not fully understood. Detection of complex fractionated atrial electrograms (CFAE) is used for this purpose. Nonetheless, efficacy of this method is inadequate in the case of chronic AF. Recent hypothesis proposes the rotors as fibrillatory substrate. Novel approaches seek to relate CFAE with rotor; nevertheless, such methods are not able to identify the associated substrate. Furthermore, the patterns that characterize CFAE generated by rotors remain unknown. Thus, tracking of rotors is an unsolved issue. In this paper, we propose a non-supervised method to find patterns associated with fibrillatory substrates in chronic AF. We extracted two features based on local activation wave detection and one feature based on non-linear dynamics. Gaussian mixture model-based clustering was used to discriminate CFAE patterns. Resulting clusters are visualized in an electroanatomic map. We assessed the proposed method in a real database labeled according to the level of fractionation and in a simulated episode of chronic AF in which a rotor was detected. Our results indicate that the method proposed can separate different levels of fractionation in CFAE, and provide evidence that clustering can be used to locate the vortex of the rotors. Provided approach can support ablation therapy procedures by means of CFAE patterns discrimination.

Vulnerability for reentry in a three dimensional model of human atria: a simulation study.

Atrial tachycardias are the most common cardiac arrhythmias in clinical practice, which induce changes in atrial properties that help to perpetuate them. These changes are called "atrial remodeling". Recent studies have shown that rapid ectopic activity principally on the pulmonary veins can trigger reentrant mechanisms and lead to atrial tachycardias. However, the influences of ectopic foci location, the number of ectopic beats and its frequency on the likelihood of triggering reentries are not well known. In this work the effects of electrical remodeling were incorporated in an atrial cell model and integrated in a three-dimensional model of human atria, to develop a study of vulnerability for reentries. To carry out the study, an ectopic beat and a burst of six ectopic beats at two different frequencies were applied in six different locations in the atria. The results show greater vulnerability in the left pulmonary veins when we applied a single ectopic beat. When we increase the number of ectopic beats to six, a greater width of the vulnerable window was observed when ectopic focus frequency was high. The location, the number of ectopic beats and their frequency affect the vulnerability for reentry.

Epidemiologia de la malaria falciparum complicada: estudio de casos y controles en Tumaco y Turbo, Colombia, 2003 / The epidemiology of complicated falciparum malaria: case and controls study in Tumaco and Turbo, Colombia, 2003

OBJETIVOS: Identificar aspectos del hospedero, del parásito y del ambiente asociados con ocurrencia de malaria por Plasmodium falciparum complicada. MÉTODOS: Estudio de casos y controles en pacientes de Tumaco y Turbo (Colombia) aplicando los criterios de complicación de la Organización Mundial de la Salud. RESULTADOS: Entre noviembre 2002 y julio 2003 se captaron 64 casos (malaria complicada) y 135 controles (malaria no complicada). Las complicaciones fueron: hiperparasitemia (40 por ciento), falla hepática (36 por ciento), síndrome dificultad respiratoria aguda (7 por ciento), falla renal (4 por ciento), trombocitopenia grave (3 por ciento), anemia grave (2 por ciento), malaria cerebral (2 por ciento) e hipoglicemia grave (1 por ciento). Se encontraron como factores de riesgo para malaria falciparum complicada: a) Los antecedentes de malaria falciparum durante el último año fueron menores en los casos (OR= 7.0 (1.2-43.6) P=0.019); b) Mayor uso previo de antimaláricos en los casos (OR=2.2 (1.1-4.4) P=0.031) y c) mayor uso de cloroquina en los casos (OR=7.4 (1.1-7.8) P=0.017). Se hallaron los alelos MAD-20 y K1 del gen msp1 y FC-27 e IC-1 del gen msp2, cuya distribución de frecuencias fue similar entre casos y controles, aunque el alelo K1 mostró una variación importante entre grupos (casos: 9.4 por ciento, controles: 3.5 por ciento). La frecuencia de "signos de peligro" fue significativamente mayor en los casos (OR= 3.3, (1.5-7.4) P=0.001). Los criterios de complicación malárica de la Organización Mundial de la Salud se comparan con otros y se discuten algunas implicaciones. CONCLUSION: Se identificaron como factores de riesgo para malaria falciparum complicada, la ausencia de antecedentes de malaria falciparum en el último año y el uso de antimaláricos antes de llegar al hospital.

OBJECTIVES: Aimed at identifying host and parasite aspects associated to the presence of Plasmodium falciparum complicated malaria. METHODS: Case and controls study in patients from Tumaco and Turbo (Colombia). We used the World Health Organization criteria to assess the presence of complicated malaria. RESULTS: A total 64 cases and 135 controls were included between November 2002 and July 2003. Observed complications were hyperparasitaemia (40 percent), liver failure (36 percent), adult respiratory distress syndrome (7 percent), renal failure (4 percent), severe thrombocytopenia (3 percent), severe anemia (2 percent), cerebral malaria (2 percent) and severe hypoglicemia (1 percent). Were identified as risk factors: a) falciparum malaria history in the previous year was lower in the cases (OR= 7.0 (1.2-43.6) P=0.019), b) the high use by the cases of antimalarials (OR=2.2, (1.1-4.4) P=0.031) and c) the high use of chloroquine by the cases (OR=7.4 (1.1-7.8), P=0.017) before attending to the hospital. Presence of P. falciparum alleles MAD-20 and K1 (msp1 gene), FC-27 and IC-1 (msp2 gene) was confirmed. No significant differences were observed in the presence of these alleles; however K1 was more frequent in cases (9.4 percent) than in controls (3.5 percent). The frequency of danger signs during the disease was significantly greater in the cases (OR= 3.3 (1.5-7.4) P=0.001). The World Health Organization criteria for complicated malaria are compared with others and some implications are discussed. CONCLUSION: They were identified as risk factors for complicated falciparum malaria, the absence of falciparum malaria antecedents in the last year and the use of antimalarials before attending to the hospital.

El tratamiento amodiaquina-sulfadoxinapirimetamina tiene eficacia del 98 por ciento para la malaria falciparum no complicada (Antioquia, Colombia; 2003) / Treatment with amodiaquine-sulfadoxine-pyrimethamine is 98 per cent effective against uncomplicated falciparum malaria

Antecedentes: la combinación amodiaquina (AQ) con sulfadoxinapirimetamina (SP) es el tratamiento de primera elección para la malaria falciparum no complicada (MFNC) en el departamento de Antioquia desde 1985 y en Colombia desde 2000. Objetivo: medir la frecuencia de falla terapéutica de AQ-SP en pacientes con MFNC, residentes en Turbo (zona de Urabá) y en El Bagre (zona del Bajo Cauca), Antioquia. Metodología: este estudio hace parte de uno mayor, que tiene diseño experimental balanceado, con ocho grupos; muestra de tamaño 50 en cada municipio, diseñada con criterios estadísticos y epidemiológicos; tratamiento aplicado en orden de llegada de los pacientes y según los esquemas usuales; seguimiento por 21 días; evaluación no ciega del efecto con el protocolo 1998 de la Organización Mundial de la Salud OMS. Resultados: se evaluaron 90 pacientes con MFNC; la falla terapéutica fue 2.2 por ciento: un caso precoz y otro tardío. El tratamiento fue bien tolerado. La parasitemia asexual se eliminó totalmente en 90 por ciento en los tres días de tratamiento (otro 10 por ciento tenía 40-80 parásitos/?L, que no es falla) y en 100 por ciento antes de 7 días de haber iniciado el tratamiento. AQ-SP mostró total capacidad de eliminar la fiebre: 100 por ciento afebriles el día 3. En los pacientes con gametocitos la cantidad de estos creció entre los días 0 y 7 y decreció luego hasta el día 21, cuando 52 por ciento los presentaban (promedio: 63 gametocitos/?L), pero no se evaluaron la viabilidad ni la fertilidad de tales gametocitos.Conclusión: el tratamiento de la MFNC con AQ-SP es altamente eficaz y debe mantenerse como la primera opción terapéutica, reforzada su eficacia antimalárica por el bajo costo, la buena tolerancia y la escasez y levedad de los efectos adversos imputables al tratamiento. AUT

Abstract Background: The combination of amodiaquine (AQ) and sulfadoxine-pyrimethamine (SP) is the firstchoice treatment for uncomplicated falciparum malaria (UCFM) in Antioquia (northwestern Colombia) since 1985 and in the country at large, since 2000. Objective: To measure the frequency of therapeutic failure of AQ-SP in patients with UCFM, residents of Turbo (Urabá zone) and El Bagre (Bajo Cauca zone) of Antioquia in northwestern Colombia. Methodology: This study is part of a larger one which has balanced design, with eight groups; the sample size in each municipality was 50 patients and it was obtained with statistical and epidemiological criteria; treatment was administered in the order of admission of patients according to the usual schedule; follow-up was done during 21 days; not-blind evaluation of the effect with the 1998 WHO protocol. Results: Ninety patients with UCFM were evaluated; therapeutic failure frequency was 2%; that is 2 cases, one early and one late. Conclusion: Treatment of UCFM with AQ-SP is highly effective and should be maintained as the first therapeutic choice; its effectiveness is reinforced by its low cost and good tolerance; also by the fact that undesirable effects attributable to the treatment are few and mild

Valores de referencia para el control de calidad de plantas medicinales como materia prima para fines terapéuticos en Colombia / Reference values for quality control of medicinal plants as raw materials for therapeutic purposes in Colombia

Se presentan los valores obtenidos, en el proceso de evaluación y desarrollo de métodos, para el control de calidad de 11 de las plantas medicinales aprobadas en Colombia: Semillas de anís (Pimpinella anisum), bulbos de ajo (Allium sativum), corteza de canela (Cinnamomum zeylanicum.), semillas de cardamomo (Elettaria cardamomum), flores de caléndula (Calendula officinalis), raíces de genciana (Gentiana lutea), hojas de hamamelis (Hammamelis virginiana), semillas de lino (Linum usitatissimum), semillas entera de trigo (Triticum aestivum), rizomas y raíces de valeriana (Valeriana officinalis) y flores de manzanilla (Matricaria chamomilla). Los análisis realizados a cada planta medicinal comprenden: La descripción morfológica macro- y microscópica, la cuantificación de cenizas totales, el contenido de sustancias extraíbles, la pérdida de peso por secado, el contenido de aceites esenciales y la identificación por cromatografía de capa fina de marcadores taxonómicos

Estudios de incompatibilidad química del alprazolam con excipientes usados en la preparación de comprimidos / Chemical incompatibility studies of alprazolamwith excipients used in tablet formulations

Ciertas asociaciones de excipientes y principios activos pueden ocasionar inestabilidad de éstos últimos hemos detectado que el alprazolam presenta incompatibilidades con algunos excipientes farmacéuticos. Se evalúa la incompatibilidad química del alprazolam con ocho excipientes que son usados en la formulación de comprimidos, en condiciones de estrés (temperatura y humedad). Cuatro de ellos presentan grupos carbonilo en su estructura química: ácido cítrico, carboximetilcelulosa, (PVPK15) y estearato de magnesio y los otros cuatro no lo presentan: almidón, metilcelulosa, talco, lactosa. La mayor degradación se obtiene con el primer grupo. El avance de la degradación se determina por la formación del principal producto de degradación del alprazolam: la triazolaminoquinoleina, el cual se cuantifica por espectrofotometría UV